| Zimmer Biomet Holdings (ZBH) | |||
|---|---|---|---|
| 119.35 -0.4 (-0.33%) | 04-26 16:00 | ||
| Open: | 119.49 | Pre. Close: | 119.75 |
| High: | 119.94 | Low: | 118.66 |
| Volume: | 1,017,137 | Market Cap: | 24,919(M) |
| Stock Technical Analysis | |
|---|---|
| Overall: |   |
| Target: | Six months: 149.58 One year: 156.40 |
| Support: | Support1: 118.63 Support2: 98.70 |
| Resistance: | Resistance1: 128.07 Resistance2: 133.90 |
| Pivot: | 122.97 |
| Moving Averages: | MA(5): 120.51 MA(20): 124.38 MA(100): 123.66  MA(250): 124.07 |
| MACD: | MACD(12,26): -1.97 Signal(12,26,9): -1.40 |
| %K %D: | %K(14,3): 12.55 %D(3): 17.12 |
| RSI: | RSI(14): 34.53 |
| 52-Week: | High: 149.25 Low: 102 Change(%): -13.8 |
| Average Vol(K): | 3-Month: 1361 10-Days: 1132 |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 120.125 - 120.847 | 120.847 - 121.384 |
| Low: | 116.916 - 117.885 | 117.885 - 118.604 |
| Close: | 118.081 - 119.508 | 119.508 - 120.567 |
| Price, MAs and Bollinger Bands |
|---|
| Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ ZBH ] has closed above bottom band by 22.7%. Bollinger Bands are 83.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 8 days. This is a sign that the current trend might continue. |
| Company profile |
|---|
| Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana. |
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Price to Book Value: | Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
| Price to Earnings: | Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
| Discounted cash flow: | Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
| Return on Assets: | Outperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
| Return on Equity: | Outperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
| Debt to Equity: | Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: New York Stock Exchange | |
| Sector: Healthcare | |
| Industry: Medical - Devices | |
| Shares Out. (M) | 205.46 |
| Shares Float (M) | 204.56 |
| % Held by Insiders | 0.13 |
| % Held by Institutions | 90.95 |
| Shares Short (K) | 4730 |
| Shares Short Prior Month (K) | 4900 |
| Stock Financials | |
|---|---|
| EPS | 4.880 |
| Book Value (p.s.) | 60.700 |
| Profit Margin | 13.85 |
| Operating Margin | 23.70 |
| Return on Assets (ttm) | 4.4 |
| Return on Equity (ttm) | 8.4 |
| Qtrly Rev. Growth | 6.3 |
| Gross Profit (p.s.) | |
| Sales Per Share | 35.968 |
| EBITDA (p.s.) | 11.924 |
| Qtrly Earnings Growth | |
| Operating Cash Flow (M) | 1580.00 |
| Levered Free Cash Flow (M) | 1140.00 |
| Stock Valuation | |
|---|---|
| PE Ratio | 24.46 |
| PEG Ratio | 2.14 |
| Price to Book value | 1.97 |
| Price to Sales | 3.32 |
| Price to Cash Flow | 15.52 |
| Stock Dividends | |
|---|---|
| Dividend | |
| Dividend Yield | |
| Dividend Growth | |
